PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

FDA Approves a New Generic Valsartan to Mitigate Shortages

by PEPID Newsroom | Mar 14, 2019 | Alerts

As of March 12, 2019 the U.S. FDA approved a new generic of Diovan (valsartan) for high blood pressure and heart failure to relieve the shortage from multiple recalls of generic valsartan products from several manufacturers. The approval of the new generic of Diovan...

Recent Posts

  • Sleep Awareness Week: Why Sleep Health Should Be Part of Every Wellness Visit
  • Heart Health Month in Practice: What Clinicians Should Watch for in February
  • National Blood Donor Month: How Clinicians Can Encourage Lifesaving Donations
  • Holiday Health Hazards: Common ER Visits and How to Prevent Them
  • What Is a DNP? Everything You Need to Know About the Doctor of Nursing Practice

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved